EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 27-Oct-2026 22:16 ET (28-Oct-2026 02:16 GMT/UTC)

New brush test detects oral cancer in one hour

Queen Mary University of London
Peer-Reviewed Publication

A paper published in the Nature journal Biomarker Research by a cross-University team led by Queen Mary University of London researchers, validates the use of a non-invasive brush biopsy test that can detect oral cancer within one hour. This inexpensive test could revolutionise oral cancer detection, and prevent unnecessary (painful) scalpel biopsies.

Journal: Biomarker Research

Novel biomarker research offers new hope in the fight against colorectal cancer

University of Sharjah
Peer-Reviewed Publication

New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are poised to reshape detection, diagnosis and treatment of the disease.

Journal: Clinica Chimica Acta

PAK1 blockade sensitizes ovarian cancer to PARP inhibitors

Compuscript Ltd
Peer-Reviewed Publication

Ovarian cancer remains the most lethal gynecological malignancy, characterized by high mortality rates and the frequent occurrence of late-stage metastatic diagnoses. While poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized ovarian cancer treatment—particularly for patients harboring BRCA1/2 mutations or deficiencies in homologous recombination (HR) repair—the emergence of PARPi resistance and the presence of HR-proficient tumors continue to limit their clinical benefit, underscoring the need for strategies to improve long-term outcomes.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities, Peking Union Medical College

Do cancer screening rates differ across sexual orientation and gender identity?

Wiley
Peer-Reviewed Publication

New research published by Wiley online in CANCER has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender identity populations.

Journal: Cancer

New tool gives scientists a clearer view of how DNA is regulated

National University of Singapore
Peer-Reviewed Publication

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore have developed a new method that allows scientists to better understand how DNA is organised and regulated inside our cells.

Journal: Nature

Vaccine against brain tumors shows promising long-term results

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital, and numerous partner institutions have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic mutation in these tumors.

Journal: Nature Cancer

New AI system provides treatment recommendations for complex blood cancers

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Peer-Reviewed Publication

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and the Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has shown a high degree of agreement with the recommendations of experienced experts and could significantly improve access to specialized and personalized cancer care.

Journal: Nature Medicine

B-cell lymphoma: Cause of high-risk disease discovered

Goethe University Frankfurt
Peer-Reviewed Publication

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists were able to identify biological characteristics of tumors, particularly in high-risk patients for whom standard therapy offers little chance of cure. In the future, such patients could receive alternative, more effective therapies directly. In addition, experimental laboratory research provided initial clues to potential therapeutic targets.

Journal: Cancer Cell

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Harvard Medical School
Peer-Reviewed Publication

A new AI model called COMPASS uses tumor gene expression data to predict which patients will respond to cancer immunotherapy drugs called immune checkpoint inhibitors. Analyzing past data from 16 clinical cohorts, COMPASS predicted ICI response 8.5 percent more accurately than the best existing approach. If validated in clinical trials, the tool could lead to better precision medicine and cancer drug development.

Journal: Nature Medicine

Study identifies a natural mechanism that limits tumour progression

CIC bioGUNE
Peer-Reviewed Publication

The work, co-led by CIC bioGUNE and IBBTEC and published in Nature Communications, identifies ASPA as a key regulator of the tumour microenvironment, opening new avenues for cancer diagnosis and therapy.

Journal: Nature Communications